Dr. GSK Velu Re-appointed as Chairman, FICCI Tamil Nadu State Council, for 5th Consecutive Year

 Dr. GSK Velu Re-appointed as Chairman, FICCI Tamil Nadu State Council, for 5th Consecutive Year


Chennai, January 22, 2026 - The Federation of Indian Chambers of Commerce and Industry (FICCI) has announced the re-appointment of Dr. GSK Velu as Chairman of the FICCI Tamil Nadu State Council for the year 2025–2026, marking his fifth consecutive year at the helm of the Council.


Dr. Velu is the Chairman and Managing Director of the Trivitron Group of Companies, Neuberg Diagnostics, and Maxivision Super Speciality Eye Hospitals. He is also Director and Shareholder at Kauvery Group of Hospitals, Director and Shareholder at Apollo Dental and Apollo Dialysis, and General & Lending Partner at Stakeboat Capital. In addition, he serves as the Honorary Consul to the Republic of Estonia in India. His continued appointment as Chairman reflects FICCI’s confidence in his ability to provide strategic direction at the intersection of healthcare, manufacturing, investment, and policy.


A distinguished healthcare entrepreneur and industry leader, Dr. Velu brings decades of experience in building affordable, high-quality healthcare and diagnostics solutions. He has played a pivotal role in strengthening India’s healthcare manufacturing and diagnostics ecosystem, while actively promoting innovation, indigenous capability building, and industry–academia collaboration. His leadership has been widely recognised through numerous national and international accolades.


Commenting on his re-appointment, Dr. GSK Velu said, “It is an honour to continue serving as Chairman of the FICCI Tamil Nadu State Council for the fifth consecutive year. Tamil Nadu stands at a critical inflection point—where manufacturing excellence, healthcare innovation, and policy collaboration must converge to create scalable, globally competitive outcomes. I look forward to working closely with industry leaders, policymakers, and stakeholders to strengthen the state’s position as a preferred destination for healthcare manufacturing, med-tech innovation, and knowledge-driven growth.”


During his tenure, Dr. Velu has been instrumental in advancing FICCI Tamil Nadu State Council’s engagement on healthcare manufacturing, diagnostics, med-tech, skilling, and industry–academia collaboration, while ensuring that industry perspectives are effectively represented in policy discourse at both the state and national levels.


His re-appointment for 2025–2026 underscores continuity, stability, and strategic leadership as FICCI Tamil Nadu State Council continues to focus on sustainable growth, innovation-led development, and enhanced global competitiveness for the state’s industry ecosystem.

Comments

Popular posts from this blog

Apollo Cancer Centres Launches Dedicated Robotic Pancreatic Surgery Program

BPCL Dealer network launches “Fuelling the Festive Spirit” Campaign

PRESTIGE HOTEL VENTURES LIMITED FILES DRHP WITH SEBI

Apollo Cancer Centres Launches ‘ColFit’, A Comprehensive Colorectal Cancer Screening Program Amidst Rising Cases

O2 Health Studio Celebrates 24th Annual Day with a Grand Finale – Miss O2 Man 2025

ABD Delivers Strong Performance in Q2FY26 Driven by Accelerated Premiumization

இந்தியர்களுக்காக எளிய ஆனால் சத்தி வாய்ந்த ‘Guaranteed Bachat Plan’-ஐ அறிமுகப்படுத்தும் பார்தி AXA லைஃப் இன்சூரன்ஸ்

Yamaha Hosts First-Ever ‘Mileage Challenge’ for FZ-S Fi Hybrid in Chennai

HCLTech தனது ஆரம்பகால தொழில் திட்டமான TechBee-க்கு விண்ணப்பங்களை வரவேற்கிறது

ஓட்டுநர் வசதியை மேம்படுத்தும் வகையில் டாடா மோட்டார்ஸ் அதன் டிரக் வரிசையில் குளிரூட்டப்பட்ட கேபின்கள் மற்றும் கௌல்களை அறிமுகப்படுத்துகிறது